
Shares of some U.S. drugmakers fall between 0.5% and 3.5% after U.S. President Donald Trump speaks on reciprocal tariffs
In extended trading, Johnson & Johnson JNJ.N down 0.6%, Moderna MRNA.O down 3.5%, Eli Lilly LLY.N down 2.4%, Bristol Myers Squibb BMY.N down 0.7% and Regeneron <REGN.O> down 2%
SPDR S&P Biotech ETF falls 4%
Tariffs on major drug trading partners include 20% on EU, 26% on India and 34% on China
*The White House makes clear that pharmaceuticals were exempt from Wednesday's tariffs as Trump plans other sectoral tariffs for semiconductors, pharmaceuticals and potentially critical minerals